Naim Shehadeh

7.8k total citations
123 papers, 3.5k citations indexed

About

Naim Shehadeh is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Naim Shehadeh has authored 123 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Surgery and 40 papers in Genetics. Recurrent topics in Naim Shehadeh's work include Diabetes Management and Research (35 papers), Pancreatic function and diabetes (32 papers) and Diabetes and associated disorders (30 papers). Naim Shehadeh is often cited by papers focused on Diabetes Management and Research (35 papers), Pancreatic function and diabetes (32 papers) and Diabetes and associated disorders (30 papers). Naim Shehadeh collaborates with scholars based in Israel, United States and United Kingdom. Naim Shehadeh's co-authors include Giora Pillar, Raanan Shamir, Afif Nakhleh, Amos Etzioni, Amir Hadash, Igor Sukhotnik, William V. Tamborlane, Pål R. Njølstad, Jørn V. Sagen and Oddmund Sövik and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Naim Shehadeh

120 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naim Shehadeh Israel 29 1.6k 1.0k 813 798 515 123 3.5k
Sami T. Azar Lebanon 35 1.3k 0.8× 564 0.5× 1.0k 1.3× 530 0.7× 564 1.1× 157 3.7k
David Hopkins United Kingdom 29 1.6k 1.0× 775 0.7× 721 0.9× 864 1.1× 480 0.9× 89 4.5k
Nebojša Lalić Serbia 29 2.3k 1.5× 980 0.9× 690 0.8× 460 0.6× 994 1.9× 137 4.0k
George Dimitriadis Greece 40 2.1k 1.4× 1.1k 1.0× 1.3k 1.6× 497 0.6× 1.4k 2.8× 185 5.6k
Vaia Lambadiari Greece 34 1.8k 1.1× 614 0.6× 906 1.1× 373 0.5× 1.0k 2.0× 181 4.6k
Bruno Geloneze Brazil 33 1.5k 0.9× 1.4k 1.4× 1.7k 2.1× 355 0.4× 509 1.0× 125 4.8k
Angelika Mohn Italy 38 1.1k 0.7× 491 0.5× 691 0.8× 589 0.7× 451 0.9× 141 3.9k
Richard M. Watanabe United States 30 1.4k 0.9× 656 0.6× 1.4k 1.7× 499 0.6× 964 1.9× 61 3.8k
Ashok Balasubramanyam United States 36 1.7k 1.1× 1.0k 1.0× 1.0k 1.3× 1.4k 1.8× 1.1k 2.1× 162 4.6k
Francisco J. Gómez‐Pérez Mexico 34 1.5k 1.0× 599 0.6× 762 0.9× 401 0.5× 868 1.7× 147 3.8k

Countries citing papers authored by Naim Shehadeh

Since Specialization
Citations

This map shows the geographic impact of Naim Shehadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naim Shehadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naim Shehadeh more than expected).

Fields of papers citing papers by Naim Shehadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naim Shehadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naim Shehadeh. The network helps show where Naim Shehadeh may publish in the future.

Co-authorship network of co-authors of Naim Shehadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Naim Shehadeh. A scholar is included among the top collaborators of Naim Shehadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naim Shehadeh. Naim Shehadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moaddel, Ruin, Julián Candia, Ceereena Ubaida‐Mohien, et al.. (2025). Healthy Aging Metabolomic and Proteomic Signatures Across Multiple Physiological Compartments. Aging Cell. 24(6). e70014–e70014.
3.
Nakhleh, Afif, et al.. (2025). Clinical and biochemical profile of individuals with renal glucosuria: A matched cohort study. Diabetes Obesity and Metabolism. 27(6). 3242–3251. 1 indexed citations
4.
5.
Nakhleh, Afif, Muhammad Abdul‐Ghani, Sivan Gazit, et al.. (2024). Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria. Diabetes Obesity and Metabolism. 26(8). 3058–3067. 4 indexed citations
6.
7.
Tamborlane, William V. & Naim Shehadeh. (2023). Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review. Advances in Therapy. 40(11). 4711–4720. 9 indexed citations
8.
Tamborlane, William V., Raafat Bishai, David H. Geller, et al.. (2022). Once-Weekly Exenatide in Youth With Type 2 Diabetes. Diabetes Care. 45(8). 1833–1840. 60 indexed citations
9.
Yefet, Enav, et al.. (2022). Cultural and Digital Health Literacy Appropriateness of App- and Web-Based Systems Designed for Pregnant Women With Gestational Diabetes Mellitus: Scoping Review. Journal of Medical Internet Research. 24(10). e37844–e37844. 21 indexed citations
10.
Tamborlane, William V., Lori M. Laffel, Naim Shehadeh, et al.. (2022). Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. The Lancet Diabetes & Endocrinology. 10(5). 341–350. 47 indexed citations
11.
Echtay, Akram, Monira Al Arouj, Naim Shehadeh, et al.. (2020). Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM). Advances in Therapy. 37(4). 1550–1563. 24 indexed citations
12.
Tamborlane, William V., Margarita Barrientos‐Pérez, Udi Fainberg, et al.. (2019). Liraglutide in Children and Adolescents with Type 2 Diabetes. New England Journal of Medicine. 381(7). 637–646. 222 indexed citations
13.
Battelino, Tadej, Larry C. Deeb, Magnus Ekelund, et al.. (2018). Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial. Pediatric Diabetes. 19(7). 1263–1270. 10 indexed citations
14.
Shehadeh, Naim, Itamar Raz, & Afif Nakhleh. (2018). Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease. Cardiovascular Diabetology. 17(1). 117–117. 9 indexed citations
15.
Elhasid, Ronit, et al.. (2008). Insulin-related metabolism following hematopoietic stem cell transplantation in childhood. Pediatric Diabetes. 10(2). 149–154. 5 indexed citations
16.
Shamir, Raanan, et al.. (2008). Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress. Pediatric Diabetes. 9(2). 104–109. 35 indexed citations
17.
Reznick, Abraham Z., et al.. (2006). Free radicals related effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes mellitus. Archives of Oral Biology. 51(8). 640–648. 87 indexed citations
18.
Shamir, Raanan, Drora Berkowitz, Eric Diamond, et al.. (2003). Serum Levels of Bile Salt-Stimulated Lipase and Breast Feeding. Journal of Pediatric Endocrinology and Metabolism. 16(9). 1289–94. 15 indexed citations
19.
Shehadeh, Naim, Raanan Shamir, Moshe Berant, & Amos Etzioni. (2001). Insulin in human milk and the prevention of type 1 diabetes. Pediatric Diabetes. 2(4). 175–177. 33 indexed citations
20.
Etzioni, Amos, Ruth Gershoni‐Baruch, Shimon Pollack, & Naim Shehadeh. (1998). Leukocyte adhesion deficiency type II: Long-term follow-up. Journal of Allergy and Clinical Immunology. 102(2). 323–324. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sami T. Azar Breakdown of academic impact, for papers by David Hopkins Breakdown of academic impact, for papers by Nebojša Lalić Breakdown of academic impact, for papers by George Dimitriadis Breakdown of academic impact, for papers by Vaia Lambadiari Breakdown of academic impact, for papers by Bruno Geloneze Breakdown of academic impact, for papers by Angelika Mohn Breakdown of academic impact, for papers by Richard M. Watanabe Breakdown of academic impact, for papers by Ashok Balasubramanyam Breakdown of academic impact, for papers by Francisco J. Gómez‐Pérez
Rankless by CCL
2026